Piciucchi, M.; Stigliano, S.; Archibugi, L.; Zerboni, G.; Signoretti, M.; Barucca, V.; Valente, R.; Fave, G.D.; Capurso, G.
The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. Int. J. Mol. Sci. 2017, 18, 730.
https://doi.org/10.3390/ijms18040730
AMA Style
Piciucchi M, Stigliano S, Archibugi L, Zerboni G, Signoretti M, Barucca V, Valente R, Fave GD, Capurso G.
The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. International Journal of Molecular Sciences. 2017; 18(4):730.
https://doi.org/10.3390/ijms18040730
Chicago/Turabian Style
Piciucchi, Matteo, Serena Stigliano, Livia Archibugi, Giulia Zerboni, Marianna Signoretti, Viola Barucca, Roberto Valente, Gianfranco Delle Fave, and Gabriele Capurso.
2017. "The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients" International Journal of Molecular Sciences 18, no. 4: 730.
https://doi.org/10.3390/ijms18040730
APA Style
Piciucchi, M., Stigliano, S., Archibugi, L., Zerboni, G., Signoretti, M., Barucca, V., Valente, R., Fave, G. D., & Capurso, G.
(2017). The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. International Journal of Molecular Sciences, 18(4), 730.
https://doi.org/10.3390/ijms18040730